FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Ambrose

Research Profile

Chemicals & Drugs

Disorders

Human Influenza

Living Beings

Procedures

Geographic Areas

United States

Concepts & Ideas

Devices

Placebos

Co-author Network

Publications

TOP 3
Seth Toback; Xionghua Wu; Christopher S Ambrose; Laurie Aukes; Abigail Eaton; John Hansen; Ned Lewis; Roger Baxter
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.
Christopher S Ambrose; Seth Toback
Improved timing of availability and administration of influenza vaccine through the US Vaccines for Children Program from 2007 to 2011.
Seth Toback; Myron J Levin; Christopher S Ambrose; Robert B Belshe; Stan L Block; Judith Falloon
Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Ambrose (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Seth Toback; Xionghua Wu; Christopher S Ambrose; Laurie Aukes; Abigail Eaton; John Hansen; Ned Lewis; Roger Baxter
A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.
Vaccine 2013;31(14):1812-8.
2013: Christopher S Ambrose; Seth Toback
Improved timing of availability and administration of influenza vaccine through the US Vaccines for Children Program from 2007 to 2011.
Clinical pediatrics 2013;52(3):224-30.
2012: Seth Toback; Myron J Levin; Christopher S Ambrose; Robert B Belshe; Stan L Block; Judith Falloon
Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
Expert review of vaccines 2012;11(11):1293-303.
2012: Patricia Tennis; Seth Toback; Elizabeth B Andrews; Lisa J McQuay; Christopher S Ambrose
A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season.
Vaccine 2012;30(42):6099-102.
2012: Seth Toback; Christopher S Ambrose
A multi-season national estimate of adult influenza vaccination by U.S. office-based pediatricians, 2006-2011.
Influenza and other respiratory viruses 2012;6(4):231-4.
2012: Seth Toback; Praful Bhatt; William Carr; Edward Rothstein; Christopher S Ambrose
In-office influenza vaccination by US pediatric providers varies greatly and is higher among smaller offices.
Clinical pediatrics 2012;51(6):551-9.
2011: Christopher S Ambrose; Tingting Yi; Judith Falloon
An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years.
Influenza and other respiratory viruses 2011;5(6):389-97.
2011: Christopher S Ambrose; Xionghua Wu
Evidence of homosubtypic but not heterosubtypic immunity in young children following wild-type influenza illness.
The Pediatric infectious disease journal 2011;30(10):900-1.
2011: Christopher S Ambrose
Efficacy and correlates of protection for cell culture-derived and egg-derived inactivated influenza vaccines in younger adults.
Expert review of vaccines 2011;10(8):1127-30.
2011: Christopher S Ambrose; Brett Loop; Robert Miday
A case report of transverse myelitis following influenza vaccination.
Archives of neurology 2011;68(8):1085; author reply 1085-6.
2011: Patricia Tennis; Seth L Toback; Elizabeth Andrews; Lisa J McQuay; Christopher S Ambrose
A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years.
Vaccine 2011;29(31):4947-52.
2011: Raburn M Mallory; Tingting Yi; Christopher S Ambrose
Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.
Vaccine 2011;29(26):4322-7.
2011: Seth L Toback; John Herley; Laurel Edelman; Christopher S Ambrose
Trends in U.S. pediatric influenza vaccination from 2006 to 2010 among children with private insurance.
Vaccine 2011;29(25):4225-9.
2011: Bruce D Forrest; Andrew Duncan Steele; Louis Hiemstra; Ruth Rappaport; Christopher S Ambrose; William C Gruber
A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
Vaccine 2011;29(20):3633-9.
2011: Seth Toback; Praful Bhatt; William Carr; Jesse Hackell; Amy Ryan; Christopher S Ambrose
Influenza vaccination of parents and guardians by US pediatricians.
Human vaccines 2011;7(4):436-40.
2011: Christopher S Ambrose; Myron J Levin; Robert B Belshe
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults.
Influenza and other respiratory viruses 2011;5(2):67-75.
2011: Stan L Block; Terho Heikkinen; Seth L Toback; Wei Zheng; Christopher S Ambrose
The efficacy of live attenuated influenza vaccine against influenza-associated acute otitis media in children.
The Pediatric infectious disease journal 2011;30(3):203-7.
2011: Harry F Hull; Christopher S Ambrose
Current experience with school-located influenza vaccination programs in the United States: a review of the medical literature.
Human vaccines 2011;7(2):153-60.
2011: Harry F Hull; Christopher S Ambrose
The impact of school-located influenza vaccination programs on student absenteeism: a review of the U.S. literature.
The Journal of school nursing : the official publication of the National Association of School Nurses 2011;27(1):34-42.
2011: Praful Bhatt; Stan L Block; Seth L Toback; Christopher S Ambrose
Timing of the availability and administration of influenza vaccine through the vaccines for children program.
The Pediatric infectious disease journal 2011;30(2):100-6.
2010: Chyongchiou J Lin; Mary Patricia Nowalk; Seth L Toback; Matthew Rousculp; Mahlon Raymund; Christopher S Ambrose; Richard Kent Zimmerman
Importance of vaccination habit and vaccine choice on influenza vaccination among healthy working adults.
Vaccine 2010;28(48):7706-12.
2010: Christopher S Ambrose; Matthew Rousculp
A valuable summary of various experiences with school-located influenza vaccination programs.
The Journal of school nursing : the official publication of the National Association of School Nurses 2010;26(5):342-3.
2010: Praful Bhatt; Stan L Block; Seth Toback; Christopher S Ambrose
A prospective observational study of US in-office pediatric influenza vaccination during the 2007 to 2009 influenza seasons: use and factors associated with increased vaccination rates.
Clinical pediatrics 2010;49(10):954-63.
2010: Christopher S Ambrose; Xionghua Wu; Robert B Belshe
The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination.
The Pediatric infectious disease journal 2010;29(9):806-11.
2010: Chin-Fen Yang; Robert B Belshe; George W Kemble; Eyun Song; Dan Ye; Brandon Liang; Tingting Yi; Christopher S Ambrose; Kathleen L Coelingh; Robert E Walker
Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine.
Vaccine 2010;28(31):5128-34.
2010: Robert B Belshe; Seth L Toback; Tingting Yi; Christopher S Ambrose
Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.
Influenza and other respiratory viruses 2010;4(3):141-5.
2010: Wei Zhu; Brandon W Higgs; Chris Morehouse; Katie Streicher; Christopher S Ambrose; Jennifer C Woo; George W Kemble; Bahija Jallal; Yihong Yao
A whole genome transcriptional analysis of the early immune response induced by live attenuated and inactivated influenza vaccines in young children.
Vaccine 2010;28(16):2865-76.
2010: Robert B Belshe; Kathleen L Coelingh; Christopher S Ambrose; Jennifer C Woo; Xionghua Wu
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
Vaccine 2010;28(9):2149-56.
2010: Raburn M Mallory; Elissa Malkin; Christopher S Ambrose; Terramika Bellamy; Li Shi; Tingting Yi; Taff Jones; George W Kemble; Filip Dubovsky
Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials.
PloS one 2010;5(10):e13755.
2009: Jennifer C Woo; Christopher S Ambrose
Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines.
Influenza and other respiratory viruses 2009;3(6):257-9.
2009: Stan L Block; Seth Toback; Tingting Yi; Christopher S Ambrose
Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
Clinical therapeutics 2009;31(10):2140-7.
2009: Janelle Rhorer; Christopher S Ambrose; Stephanie Dickinson; Holli Hamilton; Napoleon A Oleka; Frank J Malinoski; Janet Wittes
Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
Vaccine 2009;27(7):1101-10.
2009: Seth Toback; Christopher S Ambrose
Valuable data surrounding the priming and boosting abilities of various vaccine technologies.
Vaccine 2009;27(3):349.
2009: Daniel J Levy; Christopher S Ambrose; Napoleon A Oleka; Edward B Lewin
A survey of pediatricians' attitudes regarding influenza immunization in children.
BMC pediatrics 2009;9():8.
2008: Christopher S Ambrose; Catherine Luke; Kathleen L Coelingh
Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.
Influenza and other respiratory viruses 2008;2(6):193-202.
2008: Robert B Belshe; Christopher S Ambrose; Tingting Yi
Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.
Vaccine 2008;26 Suppl 4():D10-6.
2008: Stan L Block; Ram Yogev; Frederick G Hayden; Christopher S Ambrose; Wen Zeng; Robert E Walker
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Vaccine 2008;26(38):4940-6.
2008: Christopher S Ambrose; Tingting Yi; Robert E Walker; Edward M Connor
Duration of protection provided by live attenuated influenza vaccine in children.
The Pediatric infectious disease journal 2008;27(8):744-8.
2006: Christopher S Ambrose; Robert E Walker; Edward M Connor
Live attenuated influenza vaccine in children.
Seminars in pediatric infectious diseases 2006;17(4):206-12.